Stephens Investment Management Group LLC increased its holdings in Schrödinger, Inc. (NASDAQ:SDGR – Free Report) by 4.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,607,656 shares of the company’s stock after buying an additional 67,786 shares during the period. Stephens Investment Management Group LLC’s holdings in Schrödinger were worth $31,012,000 as of its most recent SEC filing.
Other hedge funds have also bought and sold shares of the company. Avanza Fonder AB bought a new position in shares of Schrödinger in the fourth quarter worth $577,000. Barclays PLC lifted its holdings in Schrödinger by 421.6% during the 3rd quarter. Barclays PLC now owns 107,554 shares of the company’s stock worth $1,995,000 after purchasing an additional 86,933 shares in the last quarter. State Street Corp boosted its stake in Schrödinger by 1.8% in the 3rd quarter. State Street Corp now owns 2,155,620 shares of the company’s stock worth $39,987,000 after purchasing an additional 38,972 shares during the period. Quest Partners LLC grew its holdings in Schrödinger by 861.0% during the 3rd quarter. Quest Partners LLC now owns 43,773 shares of the company’s stock valued at $812,000 after buying an additional 39,218 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. increased its position in shares of Schrödinger by 1.4% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,191,054 shares of the company’s stock valued at $40,644,000 after buying an additional 29,920 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.
Schrödinger Stock Performance
Schrödinger stock opened at $25.67 on Monday. Schrödinger, Inc. has a fifty-two week low of $16.67 and a fifty-two week high of $33.63. The stock has a market cap of $1.87 billion, a P/E ratio of -10.97 and a beta of 1.61. The firm’s fifty day moving average price is $21.60 and its 200-day moving average price is $20.27.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on the stock. KeyCorp raised their price objective on shares of Schrödinger from $25.00 to $27.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. BMO Capital Markets raised their price target on shares of Schrödinger from $25.00 to $28.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. Three analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $32.11.
Read Our Latest Report on SDGR
Schrödinger Company Profile
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Featured Stories
- Five stocks we like better than Schrödinger
- Learn Technical Analysis Skills to Master the Stock Market
- 3 Volatility ETFs to Help You Profit from Market Chaos
- What Are the FAANG Stocks and Are They Good Investments?
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- How to Invest in Small Cap Stocks
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
Want to see what other hedge funds are holding SDGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Schrödinger, Inc. (NASDAQ:SDGR – Free Report).
Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.